NOVEMBER 5, 2025
Julie Huntsinger, Lois Vossen and Alice Waters cordially invite you to
a private lunch to discuss Bill Haney’s new film
Cracking the Code: Phil Sharp and the Biotech Revolution
Narrated by Mark Ruffalo, Cracking the Code is an inspiring story of vision, perseverance, and the power of science to change the world. Phil Sharp’s journey from a Kentucky farm boy to Nobel laureate embodies the American Dream and the triumph of entrepreneurial spirit. His 1977 groundbreaking discovery of RNA splicing rewrote the rules of molecular biology and ignited a life-saving scientific revolution, laying the foundation for an industry that has become a cornerstone of global innovation and economic growth – and transformed the health of billions of patients worldwide.
You may preview the film on the AMPAS portal or on PBS YouTube.
Please RSVP by Tuesday, November 4th
ABOUT THE BILL HANEY
Bill Haney is a filmmaker, inventor, and entrepreneur. As a writer, director, and producer of documentary films, he has won The Gabriel Prize, A Silver Hugo, The Earthwatch Award, A Marine Conservation Award, the Golden Owl and an Amnesty International Award. Chosen as Global Leader of Tomorrow by the World Economic Forum, he has won a Humanitarian Award from Harvard Medical School, a Distinguished Service Award from the Senior Olympics, the Slow Food Prize, a Genesis Award, an Achievement Award from the ACLU, been repeatedly nominated for a NAACP Image Award, been short listed for an Oscar and won the Pare Lorentz Award. He has also written and produced several award-winning narrative films.
ABOUT PHIL SHARP
Phillip A. Sharp, PhD, an Institute Professor emeritus at MIT, is a member of the Department of Biology and the Koch Institute for Integrative Cancer Research. His work studying the molecular biology of gene expression relevant to cancer and the mechanisms of RNA splicing earned Sharp the 1993 Nobel Prize in Physiology for Medicine. Sharp is past President of AAAS, serves on the boards of directors of the Broad Institute, Stand Up 2 Cancer, and the Gairdner Foundation. He is a co-founder of Biogen and of Alnylam Pharmaceuticals and serves on the Scientific Advisory Boards of F-Prime Capital, Alnylam Pharmaceuticals, Danaher, Dewpoint Therapeutics, and Skyhawk Therapeutics, He is also advisor to Longwood and Polaris Venture Funds.
